jubilant pharmova has approved the re-appointment of its top leadership for a further term of three years. The Board of Directors approved the re-appointment of Mr. Priyavrat Bhartia as Managing Director and Mr. Arjun Shanker Bhartia as Joint Managing Director. The decision was taken during a board meeting held on May 22, 2026.

The re-appointments are effective from June 1, 2026, and are subject to the approval of the shareholders. The recommendations were based on the advice of the Nomination, Remuneration & Compensation Committee. Both directors were previously re-designated to their current roles in June 2023.

Re-appointment Details

The company disclosed the specific terms regarding the re-appointments in a regulatory filing. The table below outlines the key particulars for both directors.

Director Profiles

Mr. Priyavrat Bhartia, 49 years old, possesses around 29 years of industry experience. He holds a Bachelor's Degree in Economics from Dartmouth College, USA, and a Master's in Business Administration from Stanford University, USA. He has served on the board since May 2017.

Mr. Arjun Shanker Bhartia, aged 39, is a graduate of Brown University, USA. He began his career as an Associate Consultant with Bain & Company and has been associated with Jubilant Pharmova Limited since May 2017. The board expressed confidence that the company will benefit significantly from their leadership and strategic contributions.

Jubilant Pharmova Limited has submitted newspaper advertisements to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The advertisements were published on April 29, 2026, in Financial Express (English Language – All Editions) and Hindustan & Jansatta (Hindi language), addressing critical shareholder initiatives.

Saksham Niveshak Campaign Details

The company is participating in the second 100 Days Campaign - 'Saksham Niveshak' initiative of the Investor's Education and Protection Fund Authority (IEPFA), Ministry of Corporate Affairs (MCA). This campaign focuses on assisting shareholders in claiming unpaid or unclaimed dividends and updating their Know Your Client (KYC) and nomination details.

Shareholders with outstanding dividends or requiring KYC updates can contact the Company's Registrar and Share Transfer Agent, M/s Alankit Assignments Limited, at Alankit House, 205-208, Anarkali Complex, Jhandewalan Extension, New Delhi - 110055. The RTA can be reached at rta@alankit.com , while shareholders may also contact the company's Nodal Officer at investors@jubi.com .

Special Transfer Window for Physical Shares

In compliance with SEBI Master Circular No. HO/38/13/(4)2026 MIRSD POD/14298/2026 dated February 06, 2026, the company has announced a special window for physical share transfers. This facility continues the initiative previously advertised on February 27, 2026.

The special window accommodates re-lodgement of transfer deeds originally submitted before April 1, 2019 but were rejected, returned, or remained unattended due to documentation or procedural deficiencies. All securities processed under this window will be issued exclusively in dematerialized form and subject to a mandatory one-year lock-in period during which they cannot be transferred, lien marked, or pledged.

Important Exclusions and Requirements

The transfer facility has specific limitations that shareholders must understand:

• Disputed Cases: Matters involving disputes between transferor and transferee are not eligible and must be resolved through appropriate judicial forums such as Courts or NCLT
• IEPF Securities: Securities already transferred to the Investor Education and Protection Fund (IEPF) are not eligible for processing under this facility
• Documentation: Shareholders must contact Alankit Assignments Limited for guidance on required documentation and submission procedures

KYC Updation and Dematerialization Process

Shareholders holding physical shares are requested to update their KYC details using forms available at the company's investor portal. The required information includes PAN, Demat Account Number, Bank Account Number, Email ID, Mobile Number, and Nominee information.

For dematerialized shareholdings, investors must contact their respective Depository Participant (DP) to complete KYC updates. The company strongly encourages conversion of physical share certificates to dematerialized form for enhanced security and easier processing.

The disclosure was signed by Naresh Kapoor, Company Secretary (Membership No: A11782), and dated April 29, 2026. All information is also available on the company's website at www.jubilantpharmova.com .